
Lineage Cell Therapeutics, Inc.
LCTXHealthcare|Biotechnology|US
$1.02
+0.04 (+3.75%)
Tangible Book / Share
$0.07
Cash / Share
$0.20
Next Earnings Report
Nov 12, 2026
EPS est. -$0.03 · Revenue est. $2.3M
Financing Filings (last 12 months)
3
Shelf registrations / offering prospectuses — latest Mar 11, 2026 (S-3). Possible dilution.
Upcoming Data Readouts (3)
Dec 2026
Est. completion
Aug 2027
Est. completion
P1Spinal Cord Injury Cervical
A Study to Evaluate the Safety of a Delivery Device for Administering LCTOPC1 in Participants With Spinal Cord Injury
NCT06841770n=10
Jan 2033
Est. completion
Recent Press Releases
Lineage Provides Update on ReSonance® Program for Hearing Loss
Oct 29, 2026 · Business Wire
Lineage Cell Therapeutics Announces Issuance of Patent Underlying Its AlloSCOPE™ 5D Manufacturing Platform
Sep 8, 2026 · Business Wire
SEC Filings (51)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Aug 6, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Aug 6, 2026 | 8-K | Material event | DocumentIndex |
| Jul 29, 2026 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jun 12, 2026 | 8-K | Material event | DocumentIndex |
| May 12, 2026 | 10-Q | Quarterly report | DocumentIndex |
| May 12, 2026 | 8-K | Material event | DocumentIndex |
| Apr 29, 2026 | ARS | Annual report to holders | DocumentIndex |
| Apr 29, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 29, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Mar 23, 2026 | EFFECT | DocumentIndex | |
| Mar 11, 2026 | S-3 | Shelf registration | DocumentIndex |
| Mar 11, 2026 | 8-K | Material event | DocumentIndex |
| Mar 11, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Mar 5, 2026 | 10-K | Annual report | DocumentIndex |
| Mar 5, 2026 | 8-K | Material event | DocumentIndex |
| Nov 28, 2025 | 8-K | Material event | DocumentIndex |
| Nov 24, 2025 | 8-K | Material event | DocumentIndex |
| Nov 14, 2025 | SC 13D/A | Activist / 5%+ stake | DocumentIndex |
| Nov 12, 2025 | 8-K | Material event | DocumentIndex |
| Nov 12, 2025 | 424B3 | Offering prospectus | DocumentIndex |
| Nov 6, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Nov 6, 2025 | 8-K | Material event | DocumentIndex |
| Sep 26, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Aug 26, 2025 | 8-K | Material event | DocumentIndex |
| Aug 15, 2025 | S-8 | Employee stock plan | DocumentIndex |
| Aug 12, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Aug 12, 2025 | 8-K | Material event | DocumentIndex |
| Jul 17, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Jul 2, 2025 | 8-K | Material event | DocumentIndex |
| Jun 23, 2025 | 8-K | Material event | DocumentIndex |
| Jun 11, 2025 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Jun 9, 2025 | 8-K | Material event | DocumentIndex |
| May 13, 2025 | 10-Q | Quarterly report | DocumentIndex |
| May 13, 2025 | 8-K | Material event | DocumentIndex |
| May 1, 2025 | 8-K | Material event | DocumentIndex |
| Apr 29, 2025 | ARS | Annual report to holders | DocumentIndex |
| Apr 29, 2025 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Apr 29, 2025 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Apr 24, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Mar 10, 2025 | 10-K | Annual report | DocumentIndex |